Back

Prevalence of illicit drugs use and association with in-hospital major adverse events in patients hospitalised for acute cardiac events: the ADDICT-ICCU Trial

29 August 2022 (15:15 - 16:00)
Organised by:
Congress Presentation Part of: Acute cardiac care and COVID Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Theo Pezel

Lariboisiere APHP Site of Saint Louis University Hospital, Paris (France)

7 More presentations in this session

Presentation thumbnail
Impact of COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction.
Doctor O. Hlinomaz (Brno, CZ) Professor Z. Motovska (Prague, CZ)
Abstract Slides
Presentation thumbnail
Impact of early readmission to the cardiac ICUon in-hospital mortality and hospital length of stay in 30,942 cardiac patients.
Doctor T. Thevathasan (Berlin, DE)
Abstract Slides
Presentation thumbnail
Variables associated with bleeding and thrombotic outcomes among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomised clinical trial
Doctor P. Barros E Silva (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Atrial fibrillation in COVID-19 patients admitted to an intensive care unit: prevalence and prognosis
Doctor V. Lopes (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Dexamethasone improves cardiovascular outcomes in critically ill COVID-19, a real world scenario multicenter analysis
Doctor P. Jirak (Salzburg, AT)
Abstract Slides

Access the full session

Session thumbnail
Acute cardiac care and COVID

The Event

Event poster

ESC Congress 2022

29 August 2022 15:15 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources